Connect your AI

CTEV CTEV Payments of Debt Issuance Costs

Payments of Debt Issuance Costs at other companies

IQVIAIQV

——

Astrana HealthASTH

——

Other financials

Income statement

Revenue$244.7M+5.8%

Gross profit$175.6M+2.8%

Operating income$6.6M-31.9%

Net income-$73.6M-3.1%

EPS (diluted)-$4.41-0.7%

Balance sheet

Cash & equivalents$34.7M+2.4%

Total debt$4.7B+1.1%

Total equity-$241.1M-1,727%

Total assets$4.8B-4.8%

Cash flow

Operating cash flow-$45.8M-52.3%

CapEx$46.8M+20.3%

Free cash flow-$92.5M-34.3%

Valuation

Market cap$591.9M-10.0%

Enterprise value$5.22B—

P/S0.6×—

Profitability

Gross margin73.2%-0.9pp

Operating margin-0.5%-0.3pp

Net margin-29.3%-12.7pp

FCF margin-10.6%—

Returns & leverage

Return on equity-198.7%-274pp

Debt / equity310.9×+307×

Current ratio1.3×+0.3×

Where this comes from

Reported directly by CTEV in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's payments of debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CTEV's payments of debt issuance costs?: CTEV (CTEV) reported payments of debt issuance costs of $0 in Q1 2026.
How has CTEV's payments of debt issuance costs changed year-over-year?: CTEV's payments of debt issuance costs decreased by 100.0% year-over-year, from $4.27M to $0.